Document is current
Any future updates will be listed below
-
Authors
Coughlin, Brian https://orcid.org/0000-0002-8009-5614
Muñoz, William https://orcid.org/0000-0002-1354-3472
Kfir, Yoav https://orcid.org/0000-0002-9373-8260
Young, Michael J.
Meszéna, Domokos https://orcid.org/0000-0003-4042-2542
Jamali, Mohsen
Caprara, Irene
Hardstone, Richard https://orcid.org/0000-0002-7502-9145
Khanna, Arjun
Mustroph, Martina L.
Trautmann, Eric M.
Windolf, Charlie https://orcid.org/0000-0002-8360-7726
Varol, Erdem
Soper, Dan J.
Stavisky, Sergey D. https://orcid.org/0000-0002-5238-0573
Welkenhuysen, Marleen https://orcid.org/0000-0001-6729-9391
Dutta, Barundeb https://orcid.org/0000-0003-4781-9630
Shenoy, Krishna V.
Hochberg, Leigh R. https://orcid.org/0000-0003-0261-2273
Mark Richardson, R.
Williams, Ziv M.
Cash, Sydney S.
Paulk, Angelique C. https://orcid.org/0000-0002-4413-3417
- License Information
-
More Information
Article History
Received: 9 December 2022
Accepted: 8 June 2023
First Online: 11 September 2023
Competing interests
: K.V.S. is a consultant to Neuralink Corp. and CTRL-Labs Inc. (now a part of the Meta Reality Labs division of Meta) and is on the Scientific Advisory Boards of Mind-X Inc., Inscopix Inc. and Heal Inc. The MGH Translational Research Center has clinical research support agreements with Neuralink, Paradromics and Synchron, for which S.S.C. and L.R.H. provide consultative input. None of these entities listed are involved with this research or the Neuropixels device. B.D. and M.W. are employees of imec, a non-profit semiconductor research and development organization that manufactures, sells and distributes the Neuropixels probes, at cost, to the research community. The remaining authors declare no competing interests.
